Alta Pharmaceutical Research Center, Inc.

Dunwoody, Georgia 30338

0 studies enrolling now · 2 studies all time

What they study most

Acute Coronary Syndrome, Dyslipidemia, Type2 Diabetes

Studies at this site

• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Phase III Acute Coronary Syndrome — Stopped early